L-Carnitine 400mg/mL

L-Carnitine is an amino acid derivative (synthesized from lysine and methionine) essential for the transport of long-chain fatty acids across the inner mitochondrial membrane — the rate-limiting step for fatty acid beta-oxidation that determines how efficiently fat is burned for energy. Without carnitine, long-chain fatty acids (>12 carbons) cannot enter the mitochondrial matrix for oxidation, regardless of how much free fatty acid is available in the cell. This makes L-carnitine bioavailability a literal gating mechanism for the primary fat-burning pathway in muscle and other tissues.

The fatty acid transport mechanism involves carnitine palmitoyltransferase I (CPT-I) on the outer mitochondrial membrane, which conjugates long-chain acyl-CoA to carnitine, and CPT-II on the inner membrane, which releases the acyl group back to CoA in the matrix. The acylcarnitine intermediate crosses the inner membrane via the carnitine-acylcarnitine translocase. This entire shuttling system depends on adequate free carnitine — and carnitine deficiency (from dietary insufficiency, renal loss, or genetic disorders) produces characteristic metabolic dysfunction: impaired fat oxidation, accumulation of long-chain acylcarnitine species, hypoglycemia during fasting, and muscle weakness.

Injectable L-carnitine achieves plasma and tissue concentrations unattainable through oral supplementation alone. Oral carnitine has 14–18% bioavailability at typical doses (400–2000mg), with intestinal absorption saturation limiting uptake. Intravenous or intramuscular carnitine produces immediate high plasma concentrations that drive tissue uptake through mass action, transiently increasing intramuscular carnitine content far above what oral dosing achieves. This pharmacokinetic advantage makes injectable carnitine the modality of choice for applications where maximum carnitine delivery is desired: perioperative metabolic support, sports performance enhancement, and intensive fat loss protocols.

Beyond direct fat transport, L-carnitine serves multiple metabolic functions: carnitine carries short-chain acyl groups out of the mitochondria as acylcarnitines, preventing toxic accumulation that inhibits mitochondrial enzymes; carnitine participates in the beta-oxidation of medium-chain fatty acids; and acetyl-L-carnitine (the acetylated form) serves as a neurotransmitter precursor and acetyl group donor for acetyl-CoA synthesis in neurons and muscle. The acetyl-L-carnitine fraction of injectable carnitine preparations provides these neurological benefits alongside the metabolic effects.

Sports performance applications are well-documented: meta-analyses of carnitine supplementation show consistent effects on muscle carnitine content with high-dose injectable protocols, improvements in exercise performance at ventilatory threshold, and reduced exercise-induced muscle damage markers. The 400mg/L concentration provides 12g total (30mL vial) — appropriate for single high-dose injections or multi-dose protocols.